LHC Group, Inc. (NASDAQ:LHCG) reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The company traded as high as $136.12 and last traded at $129.21, with a volume of 2269 shares changing hands. The stock had previously closed at $127.00.
The health services provider reported $1.26 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.08 by $0.18. The company had revenue of $528.50 million during the quarter, compared to the consensus estimate of $534.15 million. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The company’s revenue was up 4.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.95 EPS.
Several research firms have recently weighed in on LHCG. UBS Group boosted their target price on shares of LHC Group from $133.00 to $136.00 and gave the stock a “buy” rating in a research report on Monday, September 23rd. Oppenheimer boosted their target price on shares of LHC Group from $125.00 to $146.00 and gave the stock an “outperform” rating in a research report on Friday, August 9th. Stephens began coverage on shares of LHC Group in a research report on Monday, October 21st. They issued an “overweight” rating and a $132.00 target price for the company. Royal Bank of Canada set a $135.00 target price on shares of LHC Group and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, September 17th. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. LHC Group has a consensus rating of “Buy” and an average target price of $130.18.
The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.16. The business’s 50-day moving average is $115.07 and its two-hundred day moving average is $117.39. The firm has a market cap of $3.91 billion, a P/E ratio of 35.59, a P/E/G ratio of 2.05 and a beta of 0.79.
LHC Group Company Profile (NASDAQ:LHCG)
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Featured Story: Dividend Reinvestment Plan (DRIP)
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.